These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9568545)

  • 1. Evidence that eosinophil infiltration in the OK-432/fibrinogen-injected Meth-A tumor in mice is mediated by locally produced IL-5.
    Ishiko T; Sakamoto K; Mita S; Kamohara H; Ogawa M
    Int J Immunopharmacol; 1997 Jul; 19(7):405-12. PubMed ID: 9568545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intratumoral injection of OK-432 in conjunction with fibrinogen greatly enhances antitumor effect on colorectal carcinomas].
    Monden T; Morimoto H; Murotani M; Yagyu T; Nagaoka H; Shimano T; Mori T
    Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):31-6. PubMed ID: 1707498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus.
    Okamoto M; Ohe G; Oshikawa T; Furuichi S; Nishikawa H; Tano T; Ahmed SU; Yoshida H; Moriya Y; Saito M; Sato M
    Cancer Immunol Immunother; 2001 Oct; 50(8):408-16. PubMed ID: 11726135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective augmentations of intratumoral 5-fluorouracil concentration by local immunotherapy with OK-432 and fibrinogen.
    Amano M; Sekimoto M; Monden T; Tomita N; Ohue M; Haba A; Sakita I; Tamaki Y; Monden M
    Dis Colon Rectum; 2000 Mar; 43(3):402-7. PubMed ID: 10733124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of antitumor effects of OK-432 against syngeneic mouse fibrosarcoma: combination effect of OK-432 and recombinant lymphokines.
    Nanjo M; Moriya Y; Hashimoto S; Kataoka M; Saito M; Yoshida T; Ishida N
    Int J Immunopharmacol; 1991; 13(2-3):205-15. PubMed ID: 1906439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of orally administered streptococcal preparation, OK-432 on murine solid tumors and its absorption from the gut.
    Nio Y; Shiraishi T; Tsuchitani T; Tobe T; Sugawara Y; Saito M; Kamiyama H
    In Vivo; 1989; 3(5):307-13. PubMed ID: 2519870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].
    Takeda T; Wakasugi T; Katsumoto Y; Sakita I; Nagaoka H; Morimoto H; Tsujinaka T; Monden T; Shiozaki H; Shimano T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1458-60. PubMed ID: 1530293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of urokinase-type plasminogen activator in local immunotherapy.
    Takeda T; Ito Y; Wakasugi E; Kobayashi T; Monden M
    Oncol Rep; 1998; 5(2):329-33. PubMed ID: 9468551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences in antitumor effect of various BRMs by intratumoral administration: induction of immunosuppressive acidic protein].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1453-6. PubMed ID: 8373204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fibrinogen to enhance the antitumor effect of OK-432. A new approach to immunotherapy for colorectal carcinoma.
    Monden T; Morimoto H; Shimano T; Yagyu T; Murotani M; Nagaoka H; Kawasaki Y; Kobayashi T; Mori T
    Cancer; 1992 Feb; 69(3):636-42. PubMed ID: 1370392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.
    Saito M; Nanjo M; Kataoka M; Moriya Y; Sugawara Y; Yoshida T; Ishida N
    Cancer Res; 1988 Aug; 48(15):4163-7. PubMed ID: 3390809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences of antitumor effect of various BRMs by intratumoral administration].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1429-32. PubMed ID: 1530288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
    Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antitumor activity of OK-432 (picibanil) by Triton X-114 phase partitioning.
    Hashimoto M; Takashige K; Furuyashiki M; Yoshidome K; Sano R; Kawamura Y; Ijichi S; Morioka H; Koide H; Oku N; Moriya Y; Kusumoto S; Suda Y
    Int Immunopharmacol; 2008 Jan; 8(1):12-9. PubMed ID: 18068095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatophagoides-farinae-induced pulmonary eosinophilic inflammation in mice.
    Yu CK; Yang BC; Lee SC; Wang JY; Hsiue TR; Lei HY
    Int Arch Allergy Immunol; 1997 Jan; 112(1):73-82. PubMed ID: 8980467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neutrophil as an information transmitter in tumor inhibition by a streptococcal biological response modifier, OK-432.
    Sato T; Midorikawa Y; Yamashita T; Araki A; Sendo F
    Cancer Immunol Immunother; 1996 Oct; 43(2):77-86. PubMed ID: 8954141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combination therapy of radiation and local administration of OK-432 on a murine fibrosarcoma.
    Mukai M; Ando K; Koike S; Nagao K
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):125-30. PubMed ID: 2745186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
    Baba H; Tsujitani S; Korenaga D; Kakeji Y; Haraguchi M; Konoe S; Maehara Y; Sugimachi K
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1596-9. PubMed ID: 2389954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between anti-tumor effect and delayed hypersensitivity induced by topically applied OK-432 with histological findings].
    Kokunai I; Mori T; Yayoi E; Matuura N; Kosaki G
    Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):258-65. PubMed ID: 3982380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.